Latest in Replacing Ozempic
Sort by
11 items
-
The Ozempic Shortage Is Over—for Now
The resolution could potentially restrict how telehealth programs offer cheaper versions known as compounded drugs.Inc. - 1d -
The Ozempic Shortage Is Over
The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive changes.Wired - 1d -
-
FDA declares end to Wegovy and Ozempic shortage
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.CBS News - 1d -
IOC finds Olympic sponsor in China through 2032 to replace Panasonic of Japan
The International Olympic Committee has found a sponsor in China to replace long-term commercial partner Panasonic from JapanABC News - 2d -
Europe seeks to replace imported Russian fertilisers with local manure
Commission expected to approve greater use of Renure, a product based on dung, to lower costs and boost efficiencyFinancial Times - 1d -
Transfer rumors, news: Liverpool look at Wesley to replace Alexander-Arnold
Liverpool could need to find a replacement for right-back Trent Alexander-Arnold and have targeted Flamengo's Wesley. Transfer Talk has the latest news, gossip and rumors.ESPN - 6h -
Has international hockey replaced the NHL All-Star Game for good?
The 4 Nations Face-Off was a game-changer. How will the NHL capitalize on it -- and what comes next for its midseason events?ESPN - 5h -
FDA says Ozempic and Wegovy shortage is ending. That’s bad news for this wellness stock.
“We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.MarketWatch - 1d -
Ozempic and Wegovy officially moved off FDA's drug shortage list
Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed from the Food and Drug Administration's (FDA) drug shortage list nearly ...The Hill - 21h -
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
The FDA's decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.CNBC - 22h